- November 5, 2019
- Category: Drugs and Therapeutics, Healthcare and LifeSciences
Global Lateral Epicondylitis (Tennis Elbow) Market Size Study, by Treatment Type (Shock Wave Therapy, Surgery, Corticosteroid Injections, Painkillers and Nsaids, Equipment and Other Products), and Regional Forecasts, 2019-2026 (USD Billion/Million)
Product Code: | HALDAT_71317805 |
Chapter 1. Executive Summary 1.1. Market Snapshot 1.2. Key Trends 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion) 1.3.1. Lateral Epicondylitis (Tennis Elbow) Market, by Treatment Type, 2016-2026 (USD Billion) 1.3.2. Lateral Epicondylitis (Tennis Elbow) Market, by Region, 2016-2026 (USD Billion) 1.4. Estimation Methodology 1.5. Research Assumption Chapter 2. Global Lateral Epicondylitis (Tennis Elbow) Market Definition and Scope 2.1. Objective of the Study 2.2. Market Definition & Scope 2.2.1. Industry Evolution 2.2.2. Scope of the Study 2.3. Years Considered for the Study 2.4. Currency Conversion Rates Chapter 3. Global Lateral Epicondylitis (Tennis Elbow) Market Dynamics 3.1. See Saw Analysis 3.1.1. Market Drivers 3.1.2. Market Challenges 3.1.3. Market Opportunities Chapter 4. Global Lateral Epicondylitis (Tennis Elbow) Market Industry Analysis 4.1. Porter’s 5 Force Model 4.1.1. Bargaining Power of Buyers 4.1.2. Bargaining Power of Suppliers 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.1.6. Futuristic Approach to Porter’s 5 Force Model 4.2. PEST Analysis 4.2.1. Political Scenario 4.2.2. Economic Scenario 4.2.3. Social Scenario 4.2.4. Technological Scenario 4.3. Key Buying Criteria (On Demand) 4.4. Regulatory Framework (On Demand) 4.5. Investment Vs Adoption Scenario (On Demand) 4.6. Analyst Recommendation & Conclusion Chapter 5. Global Lateral Epicondylitis (Tennis Elbow) Market, by Treatment Type 5.1. Market Snapshot 5.2. Market Performance - Potential Model 5.3. Lateral Epicondylitis (Tennis Elbow) Market, Sub Segment Analysis 5.3.1. Corticosteroid Injections 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 5.3.2. Surgery 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 5.3.3. Shock Wave Therapy 5.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 5.3.4. Painkillers and Nsaids 5.3.4.1. Market estimates & forecasts, 2016-2026 (USD Billion) 5.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) Chapter 6. Global Lateral Epicondylitis (Tennis Elbow) Market, by Regional Analysis 6.1. Lateral Epicondylitis (Tennis Elbow) Market, Regional Market Snapshot (2016-2026) 6.2. North America Lateral Epicondylitis (Tennis Elbow) Market Snapshot 6.2.1. U.S. 6.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.2.1.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.2.2. Canada 6.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.2.2.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.3. Europe Lateral Epicondylitis (Tennis Elbow) Market Snapshot 6.3.1. U.K. 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.3.1.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.3.2. Rest of Europe 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.3.2.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.4. Asia Lateral Epicondylitis (Tennis Elbow) Market Snapshot 6.4.1. China 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.4.1.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.4.2. India 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.4.2.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.4.3. Japan 6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.4.3.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.4.4. Rest of Asia Pacific 6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.4.4.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.5. Latin America Lateral Epicondylitis (Tennis Elbow) Market Snapshot 6.5.1. Brazil 6.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.5.1.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.5.2. Mexico 6.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.5.2.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 6.6. Rest of The World 6.6.1. Middle East and Africa 6.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion) 6.6.1.2. Treatment Type breakdown estimates & forecasts, 2016-2026 (USD Billion) Chapter 7. Competitive Intelligence 7.1. Company Market Share (Subject to Data Availability) 7.2. Top Market Strategies 7.3. Company Profiles 7.3.1. Moecular Pharmacology Limited 7.3.1.1. Overview 7.3.1.2. Financial (Subject to Data Availability) 7.3.1.3. Product Summary 7.3.1.4. Recent Developments 7.3.2. Chugai Pharmaceuticals Co. Ltd. 7.3.3. Seikagaku Corporation 7.3.4. Kasiak Research Pvt Ltd. 7.3.5. Teikoku Pharma Inc. Chapter 8. Research Process 8.1. Research Process 8.1.1. Data Mining 8.1.2. Analysis 8.1.3. Market Estimation 8.1.4. Validation 8.1.5. Publishing 8.1.6. Research Assumption
Global Lateral Epicondylitis (Tennis Elbow) Market industry valued approximately USD 8679.9 million in 2018 is anticipated to grow with a healthy growth rate of more than 3.20% over the forecast period 2019-2026. The major factors driving the growth of the Market is due to growth in healthcare sector, prevalence of lateral epicondylitis and growing high-risk geriatric population. However, lack of skilled professionals coupled with lethargic commercialization of the therapies is expected to hinder the market growth over the forecast period.
The regional analysis of global Lateral Epicondylitis (Tennis Elbow) market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the high level of awareness among the population in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising disposable income, rising incidences of sports injuries and improving healthcare infrastructure would create lucrative growth prospects for the Lateral Epicondylitis (Tennis Elbow) market across Asia-Pacific region.
Major market player included in this report are:
Teikoku Pharma, Inc.
Kasiak Research Pvt Ltd.
Chugai Pharmaceuticals Co Ltd.
Seikagaku Corporation
Moecular Pharmacology Limited
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Corticosteroid Injections
Painkillers and Nsaids
Equipments and Other Products
Shock Wave Therapy
Surgery
By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, the years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026
Target Audience of the Lateral Epicondylitis (Tennis Elbow) Market Study
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors